A water-based thin-film calcium-phosphate technology developed by PNNL will soon enhance bone bonding and reduce the body's chance for post-surgical infection and implant rejection.It was licensed in 2004 to Bacerin (www.bacerin.com),and will be commercialized later this year as part of Bacerin's ElutiaWound Drain series (a second-generation drain).
展开▼
